The fast-growing firm saw its stock price drop 35 percent after intense scrutiny of rising drug costs.
The market is expected to generate $2.8 billion in sales in 2015, growing to $3.4 billion by 2020.
Glaucoma surgeries are expected to rise to nearly 1.4 million by 2020.
Doctors openly shared surgical experiences and the best choices for a successful outcome.
39 percent of US cataract surgeons now have access to femtosecond technology, according to Market Scope’s Q2-2015 survey.
The funding will also help launch the product in Europe in 2016.
The creator of the “iris claw” lens (now known as the Artisan) also founded Ophtec with his wife.
The operation was part of an ongoing clinical trial assessing the use of cultured retinal pigment epithelial cells derived from human embryonic stem cells.
The publicly funded health care system is a frequent political football, but concerns over its future appear to be taking on new urgency.
You are not currently logged in.
©2017 Market Scope
Lost your Password